BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2005672)

  • 1. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
    Chen HC; Lai YH; Tsai CY; Shin SJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
    Amair P; Khanna R; Leibel B; Pierratos A; Vas S; Meema E; Blair G; Chisolm L; Vas M; Zingg W; Digenis G; Oreopoulos D
    N Engl J Med; 1982 Mar; 306(11):625-30. PubMed ID: 7035945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is continuous ambulatory peritoneal dialysis the best dialysis choice for insulin dependent diabetics?
    Rottembourg J; de Groc F; Poignet JL; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():215-20. PubMed ID: 6348737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of insulin by continuous ambulatory peritoneal dialysis.
    Chan E; Montgomery PA
    Pharmacotherapy; 1993; 13(5):455-60. PubMed ID: 8247911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical aspects of continuous ambulatory peritoneal dialysis in diabetics].
    Rottembourg J; Issad B; Allouache M; Ruotolo C; Deray G; Baumelou A; Kahn JF; Jacobs C
    Nephrologie; 1988; 9(5):227-32. PubMed ID: 3063989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Program of continuous ambulatory peritoneal dialysis and renal transplantation in insulin-dependent diabetics in the terminal stage of renal insufficiency].
    Mousson C; Tanter Y; Chalopin JM; Rifle G
    Nephrologie; 1987; 8(4):205-9. PubMed ID: 3320798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
    Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
    [No Abstract]   [Full Text] [Related]  

  • 8. [Continuous ambulatory peritoneal dialysis in diabetic patients].
    Stojimrović B; Nesić V
    Srp Arh Celok Lek; 1998; 126(7-8):277-82. PubMed ID: 9863395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term continuous ambulatory peritoneal dialysis in diabetics.
    Balaskas EV; Yuan ZY; Gupta A; Meema HE; Blair G; Bargman J; Oreopoulos DG
    Clin Nephrol; 1994 Jul; 42(1):54-62. PubMed ID: 7923968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAPD and transplantation in diabetics.
    Passlick J; Grabensee B
    Clin Nephrol; 1988; 30 Suppl 1():S18-23. PubMed ID: 3052957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
    Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
    Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
    Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
    Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy.
    Grefberg N; Danielson BG; Nilsson P
    Acta Med Scand; 1984; 215(5):427-34. PubMed ID: 6377827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2 year evaluation of diabetic patients on continuous ambulatory peritoneal dialysis.
    Coronel F; Naranjo P; Torrente J; Gallego E; Domingo C; Prats D; Barrientos A
    J Diabet Complications; 1987; 1(1):20-5. PubMed ID: 2968992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Continuous ambulatory peritoneal dialysis treatment and blood glucose control in diabetics with end-stage diabetic nephropathy].
    Li GW; Liu J; Chen L
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):360-3, 382. PubMed ID: 2684575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials.
    Almalki MH; Altuwaijri MA; Almehthel MS; Sirrs SM; Singh RS
    Clin Invest Med; 2012 Jun; 35(3):E132-43. PubMed ID: 22673316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of therapeutic efficacy of continuous ambulatory peritoneal dialysis between diabetic and non-diabetic patients: three years of experience.
    Tsai TJ; Tsai HF; Wu MS; Chuang CM; Chen WY
    Taiwan Yi Xue Hui Za Zhi; 1989 Oct; 88(10):1000-7. PubMed ID: 2699488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.